A Clinical Trial to Evaluate the effect of an Ayurvedic Regimen administered in (COVID â?? 19) Patients

INTERVENTION: Intervention1: Ayurvedic Regimen: Divya Swasari Vati 2 tablets orally with luke‐warm water, thrice a day, half an hour before the breakfast, lunch and dinner. Divya Coronil Tablet2 tablets orally with luke‐warm water, thrice a day, half an hour after the breakfast, lunch and dinner. Divya Anu Taila (For Nasal Therapy) 4 drops of Anu Taila in both the nostrils, once per day, relatively 1 hour before breakfast. Control Intervention1: Placebo Group: Placebo against Divya Swasari Vati Placebo against Divya Coronil Placebo Nasal drop aganist anu taila CONDITION: Health Condition 1: B338‐ Other specified viral diseases PRIMARY OUTCOME: To render proportion of patient showing clinical improvement in mild, moderate and severe COVID‐19 cases. ; Mean time (days) for clinical recovery. ; Timepoint: Details will be recorded on Day 0 i.e. the day of admission (baseline), Day 3, Day 7 ,Day 14 and on one follow up visit on Day 28. ; SECONDARY OUTCOME: To restore health and reduction in serum viral load. ; Rate of patients with negative SARS‐CoV2 on nasal or throat swab RT‐PCR test. ; Reduction in increased immunological markers like IL6 and other relevant markers like quantitative CRP, Serum LDH, TLC. ; â?¢ Drug related side effects and toxicity, and tolerability. ; Health status improvement in Quality of life through WHO QOL bref questionnaire. ; Timepoint: Details will be recorded on Day 0 i.e. the day of admission (baseline), Day 3, Day 7 ,Day 14 and on one follow up visit on Day 28. ; INCLUSION CRITERIA: Age 18‐ 60 years of both male and female gender. Laboratory confirmed COVID‐19 patients determined through (RT‐PCR). Patient consenting to participate in the study and follow instructions. Agree to attend hospital for follow up on predetermined schedule.